Side by side, hype turned down
Compare peptide evidence—not the marketing.
These guides group commonly searched peptides without pretending they are interchangeable or naming a universal “best.”
GLP-1 peptides compared in plain English
How semaglutide, tirzepatide, liraglutide, and investigational retatrutide differ in targets, evidence, and approval status.
Status + evidence + uncertainty
Peptides for weight management: approved versus experimental
A status-first look at approved medicines and experimental peptides discussed for body weight.
Status + evidence + uncertainty
Peptides for recovery: what evidence exists?
What the evidence really says about BPC-157, thymosin beta-4, CJC-1295, and ipamorelin for injury recovery.
Status + evidence + uncertainty
Peptides for skin and aging: research versus hype
A careful guide to peptide research, cosmetic ingredients, injectable claims, and the slippery word “anti-aging.”
Status + evidence + uncertainty
Growth hormone pathway peptides: what readers should understand
How tesamorelin, sermorelin, CJC-1295, and ipamorelin differ in mechanism, status, and evidence.
Status + evidence + uncertainty